Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Methyldopa | The risk or severity of adverse effects can be increased when Methyldopa is combined with Lithium chloride. |
| Insulin human | The therapeutic efficacy of Insulin human can be increased when used in combination with Lithium chloride. |
| Insulin lispro | The therapeutic efficacy of Insulin lispro can be increased when used in combination with Lithium chloride. |
| Insulin glargine | The therapeutic efficacy of Insulin glargine can be increased when used in combination with Lithium chloride. |
| Insulin pork | The therapeutic efficacy of Insulin pork can be increased when used in combination with Lithium chloride. |
| Insulin aspart | The therapeutic efficacy of Insulin aspart can be increased when used in combination with Lithium chloride. |
| Insulin detemir | The therapeutic efficacy of Insulin detemir can be increased when used in combination with Lithium chloride. |
| Insulin glulisine | The therapeutic efficacy of Insulin glulisine can be increased when used in combination with Lithium chloride. |
| NN344 | The therapeutic efficacy of NN344 can be increased when used in combination with Lithium chloride. |
| Insulin beef | The therapeutic efficacy of Insulin beef can be increased when used in combination with Lithium chloride. |
| Insulin degludec | The therapeutic efficacy of Insulin degludec can be increased when used in combination with Lithium chloride. |
| Insulin argine | The therapeutic efficacy of Insulin argine can be increased when used in combination with Lithium chloride. |
| Insulin peglispro | The therapeutic efficacy of Insulin peglispro can be increased when used in combination with Lithium chloride. |
| Insulin tregopil | The therapeutic efficacy of Insulin tregopil can be increased when used in combination with Lithium chloride. |
| Cisatracurium | Lithium chloride may increase the neuromuscular blocking activities of Cisatracurium. |
| Bexagliflozin | The serum concentration of Lithium chloride can be decreased when it is combined with Bexagliflozin. |
| Dapagliflozin | The serum concentration of Lithium chloride can be decreased when it is combined with Dapagliflozin. |
| Ertugliflozin | The excretion of Lithium chloride can be increased when combined with Ertugliflozin. |
| Insulin icodec | The therapeutic efficacy of Insulin icodec can be increased when used in combination with Lithium chloride. |
| Palopegteriparatide | The risk or severity of hypercalcemia can be increased when Lithium chloride is combined with Palopegteriparatide. |